pharmaphorum

JANUARY 19, 2022

Just months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion in funding secured from investors. Dubbed an ‘anti-ageing’ company, Altos has gained mainstream attention for its focus on ‘rejuvenation’ and biological reprogramming technology. While the specific research goals have been kept a closely guarded secret, some scientists propose that rejuvenating cells in a lab could be a path to prolonging huma

130

130

Fierce Healthcare

JANUARY 19, 2022

Fierce JPM Week: Women are the 'power buyers' of healthcare. Here's how to serve them better. hlandi. Wed, 01/19/2022 - 13:54.

140

140

pharmaphorum

JANUARY 19, 2022

The digital revolution generated by the pandemic fractured lines of connection and severed the life-blood of being able to meet with clinicians for sales teams and MSLs. It created a fundamental shift in operating practice that has skewed product launches, sales and scientific communication but experts are advocating that companies embrace the change and use it to energise performance.

Communication 98

Communication 98

Fierce Healthcare

JANUARY 19, 2022

Bullish on growing use of telehealth, Wheel banks $150M to expand white-labeled virtual care services. hlandi. Wed, 01/19/2022 - 16:26.

Labelling 117

Labelling 117

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fossil Remedies

JANUARY 19, 2022

We know that the PCD Pharma Franchise business is lucrative and profitable. But do we know which PCD products should we pick so that the maximum profitability is ensured? Perhaps no. This blog is an attempt to clarify the concepts about choosing the best products. First, choose the right company. Experts say that one should choose an ISO-certified company that works as per the standards and guidelines laid by WHO and GMP.

98

98

Pharma Marketing Network

JANUARY 19, 2022

Talk to me. Pharma brands that want deep engagements need to look at and listen to social audio. It’s not surprising. In fact, it’s the most direct route to your goal. You want to talk to doctors? To start the conversation, we put pictures in front of them, bombarded them with videos, retarget them, and then send them emails. We want to talk, and they want to listen.

97

97

pharmaphorum

JANUARY 19, 2022

Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process. The collaboration aims to “close the gap between single-cell RNA sequencing wet-lab services and single-cell data analysis solutions,” which will allow scientists to study the finest details that can be hard to access.

72

72

Fierce Healthcare

JANUARY 19, 2022

CMMI taking hard look at Medicare Advantage coding practices and impact on payment models. rking. Wed, 01/19/2022 - 16:10.

115

115

pharmaphorum

JANUARY 19, 2022

Lung cancer drug sugemalimab has delivered positive results following a phase 3 trial. EQRx’s GEMSTONE-302 study evaluated the efficacy and safety of the investigational anti-PD-L1 antibody, sugemalimab, in combination with chemotherapy as a first-line treatment for patients with stage four non-small cell lung cancer (NSCLC), versus using chemotherapy alone.

Chemotherapy 59

Chemotherapy Immunization 59

Fierce Healthcare

JANUARY 19, 2022

Big Health hauls in $75M to ramp up commercialization, launch new digital mental health therapeutics. dmuoio. Wed, 01/19/2022 - 11:18.

109

109

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JANUARY 19, 2022

Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade. Yet how many other therapy areas have market leaders that don’t even have clinical approval in that indication?

Cerner 52

Cerner 52

Fierce Healthcare

JANUARY 19, 2022

In its 2nd deal in 2 weeks, Babylon picks up DayToDay Health to bolster its remote care portfolio. rtorrence. Wed, 01/19/2022 - 15:28.

107

107

pharmaphorum

JANUARY 19, 2022

Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for $65 million (£47.7 million) to end their legal battle over Endo’s role in the opioid epidemic in the United States. The announcement comes at the same time as the state has finalised its nearly $300 million (£220 million) settlement with Johnson & Johnson that was announced in July, part of a multi-state settlement deal that also included distributors Amer

52

52

Fierce Healthcare

JANUARY 19, 2022

Lyra Health gets $235M, soars to $5.85B valuation with new acquisition for global expansion. rtorrence. Wed, 01/19/2022 - 11:22.

107

107

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 19, 2022

The success of any drug launch begins long before a regulatory agency gives the product the green light. From clinical development to commercialization, cross?functional team collaboration is critical when bringing a new drug to market—even more so when the product is fast?tracked or receives priority review. In the case of a company’s first commercial launch, the metaphor “building the plane while flying it” is often cited because so much is in progress.

52

52

Fierce Healthcare

JANUARY 19, 2022

UnitedHealth Group reports $4.1B in profit for Q4, $17.3B for full-year 2021. pminemyer. Wed, 01/19/2022 - 07:23.

112

112

Med Ed 101

JANUARY 19, 2022

Lasmiditan (Reyvow) is an agent that can be utilized for acute migraine treatment. It works slightly differently than triptans. While triptans target serotonin receptor subtypes 1B and 1D, lasmiditan targets serotonin receptor subtype 1F. The biggest reason that this matters is that by having selective agonist activity at 1F, we can likely avoid some of […].

40

40

Fierce Healthcare

JANUARY 19, 2022

Mark Cuban's drug company launches pharmacy, promising striking savings on generic drugs. agliadkovskaya. Wed, 01/19/2022 - 12:09.

112

112

Pharma Times

JANUARY 19, 2022

Imfinzi has shown improvements in the overall survival of patients with biliary tract cancer

45

45

Fierce Healthcare

JANUARY 19, 2022

Providers more likely to use negative descriptors in Black patients' medical records, study finds. dmuoio. Wed, 01/19/2022 - 15:17.

Medical Records 91

Medical Records 91

Pharma Times

JANUARY 19, 2022

NICE also aims to make strides in digital, genomic and antimicrobial technologies

45

45

Fierce Healthcare

JANUARY 19, 2022

How 24/7 remote cardiac monitoring can cut diagnosis time, according to one tech company. agliadkovskaya. Wed, 01/19/2022 - 16:03.

62

62

Fierce Healthcare

JANUARY 19, 2022

Biden confident he can get 'big chunks' of $1.75T Build Back Better Act signed into law. rking. Wed, 01/19/2022 - 17:12.

126

126